Attached files
file | filename |
---|---|
EX-32.2 - EX-32.2 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex322_11.htm |
EX-31.2 - EX-31.2 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex312_13.htm |
EX-31.1 - EX-31.1 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex311_9.htm |
10-Q - 10-Q - HTG MOLECULAR DIAGNOSTICS, INC | htgm-10q_20170930.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of HTG Molecular Diagnostics, Inc. (the “Company”) on Form 10-Q for the quarter ending September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to my knowledge that:
|
(1) |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 7, 2017 |
|
By: |
/s/ Timothy B. Johnson |
|
|
|
Timothy B. Johnson |
|
|
|
President and Chief Executive Officer |
|
|
|
(Principal Executive Officer) |